Open AccessAbstract 3180: Preclinical validation of EZH2 as a therapeutic target in pediatric Ewing's sarcoma
Author(s) -
Pankita H. Pandya,
Barbara J. Bailey,
Adily E. Elmi,
Heather R. Bates,
Courtney Hemenway,
Anthony L. Sinn,
Khadijeh Bijangi-Vishehsaraei,
M. Reza Saadatzadeh,
Harlan E. Shan,
Junhua Ding,
Mark S. Marshall,
Michael J. Ferguson,
Lijun Cheng,
Lang Li,
Mary Ellen Murray,
Jamie Renbarger,
Karen E. Pollok
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-3180
Subject(s) - ezh2 , cancer research , prc2 , enhancer , biology , carcinogenesis , epigenetics , gene , transcription factor , medicine , genetics